Rachel Haurwitz
Founder bij CARIBOU BIOSCIENCES, INC.
Vermogen: 28 M $ op 29-02-2024
Profiel
Founder of Intellia Therapeutics, Inc. and Caribou Biosciences, Inc., Rachel E.
Haurwitz holds the position of President, Chief Executive Officer & Director at Caribou Biosciences, Inc. She is also on the board of Biotechnology Innovation Organization, BIOCOM and Seer, Inc. (California).
In her past career Dr. Haurwitz held the position of Class II Director at Intellia Therapeutics, Inc.
Rachel E.
Haurwitz received a doctorate from the University of California, Berkeley and an undergraduate degree from Harvard College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
20-02-2024 | 3 508 095 ( 3.97% ) | 28 M $ | 29-02-2024 | |
SEER, INC. CLASS A
0.05% | 14-06-2023 | 29 437 ( 0.05% ) | 53 575 $ | 29-02-2024 |
Actieve functies van Rachel Haurwitz
Bedrijven | Functie | Begin |
---|---|---|
CARIBOU BIOSCIENCES, INC. | Founder | 28-10-2011 |
SEER, INC. | Director/Board Member | 08-11-2021 |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 26-02-2019 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01-02-2020 |
Eerdere bekende functies van Rachel Haurwitz
Bedrijven | Functie | Einde |
---|---|---|
INTELLIA THERAPEUTICS, INC. | Founder | 01-11-2016 |
Opleiding van Rachel Haurwitz
University of California, Berkeley | Doctorate Degree |
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CARIBOU BIOSCIENCES, INC. | Health Technology |
INTELLIA THERAPEUTICS, INC. | Health Technology |
SEER, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |